Sign in to baba News

The Desk, the news read to you every hour, is part of News Plus.

or use an email code

By continuing you agree to the terms and privacy policy.

News Plus · The Desk

The news, read to you every hour

A short spoken bulletin on the stories that moved in the last hour, from 6:00 to 23:00 Israel time. In English.

Also in News Plus

  • What changed since you read it
  • The daily brief by email
  • Headlines side by side
  • Duki without the daily limit

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

News Plus

Welcome, one more step

The cross-newsroom layer: who covered a story, who didn’t, and how each one worded it. Plus your own news, on every device.

Follow your news

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email

See the coverage

  • Headlines side by side
  • Who reported first
  • Every newsroom clip, from every platform
  • Every newsroom photo on a story

Go deeper

  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Free stays free: the live wire, Not Everywhere, the brief, five follows and five Duki questions a day.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

By continuing you agree to the terms and privacy policy.

News Plus · Ask Duki

Keep asking Duki

A free account gets five questions a day. News Plus lifts the daily limit.

Also in News Plus

  • The whole archive
  • Headlines side by side
  • Who reported first
  • The Desk, every hour

Full coverage· Tech· Updated

Israeli AI Founder Maor Shlomo Launches Private Cancer Research Investment Fund

Maor Shlomo, founder of Israeli AI startup Base44, has launched a private investment fund focused on cancer research and innovative therapies, motivated by his mother's recent death from cancer. The fund has invested in seven companies over four months, aiming to accelerate drug development and testing through AI technologies. Shlomo calls for additional investors to join and plans to share further details soon.

2 newsrooms · 1 language · since

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

By continuing you agree to the terms and privacy policy.

Israeli AI Founder Maor Shlomo Launches Private Cancer Research Investment Fund
Illustration by baba

What happened

  1. 01Maor Shlomo founded a private cancer research investment fund after losing his mother to cancer.
  2. 02The fund has invested in seven companies in four months, focusing on breakthrough therapies.
  3. 03Shlomo emphasizes AI's role in speeding drug design and identifies manufacturing and testing as new bottlenecks.
  4. 04He highlights companies like Starget Pharma, CuResponse, Cellint, and Baccine in his portfolio.
  5. 05Shlomo continues leading Base44 while supporting portfolio firms with AI expertise.
  6. 06He invites others to invest or assist and will announce more fund details later.
Translated and summarized by baba from Ynet, the latest report. Read Ynet’s original

The coverage

2 newsrooms on this story

Who covered it

  • LeftNone
  • Centre1
  • RightNone
  • HarediNone
  • ArabNone
  • Other1

How it broke

Plus

News Plus · Who reported first

See which newsroom broke it

The order the newsrooms filed in, and how long each side of the press waited before running the story.

Also in News Plus

  • Headlines side by side
  • Story alerts
  • The Live Terminal
  • Unlimited follows